Sprinklr Announces Second Quarter Fiscal 2024 Results

Go back to Sprinklr Announces Second Quarter Fiscal 2024 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 7.44 -0.16 (2.11%)
Previous Close $7.60    52 Week High $1.44 
Open $7.40    52 Week Low $0.06 
Day High $7.44    P/E N/A 
Day Low $7.40    EPS $-1.24 
Volume 851,551